Born 1973. CEO since 2015.
Justin has a Master’s degree (M.S.) in European commercial law from Lund University and has completed his doctorate (Ph.D.) in law at Lund University. Justin took over as CEO of Magle Life Sciences in 2015 after being an advisor since 2012. During this time, Justin has overseen the acquisition of Chemoswed and Adroit Science, and the merger and structuring of Magle Chemoswed.
Shareholding: 150 000 warrants
Born 1978. CFO since 2020.
Petra has more than 8 years of finance experience in the life-science industry, start up companies, and of the executive leadership teams. Petra holds a degree of excellence in Business Management and Business finance, IHM Business School, Malmö. Petra has a hands-on mentality that gives us an added value to our company.
Shareholding: –
Born1976. Chief Operations Officer since 2019.
Fredrik holds a bachelor’s degree (B.Sc.) in chemical engineering with a specialization in pharma from Malmö University, and has a long background in analytical chemistry and drug development. He has worked within the organization since 1999 and has been part of Magle Chemoswed’s senior management since 2019.
Shareholding: 75 000 warrants
Camilla has a background in chemical Technology (drug formulation) from Lund University. She has more than 20 years of experience from the pharmaceutical industry mainly within pharmacokinetics, analytical chemistry, and management, supporting projects in early discovery to late clinical phase. Camilla is the Team Leader of Project Management Office managing early development and late clinical phase, external and internal projects.
Heléne Giordano is responsible for Quality Control and Analytic Development. Heléne has over 30 years of experience in life sciences and is responsible for supporting operations in commercial and development phases. Heléne is a proven leader and supports the operations across the full supply chain and ensures patient safety and product conformity.
Malin has spent 20 years in the health care industry in roles covering Development Engineer, Project Management of New Product Development projects, Quality Management Systems, Quality and Regulatory Affairs.The Compliance team covers subject matter experts within Quality Assurance, Regulatory Affairs, Risk Management, Audit Management, Validation & Qualification, Environment, Health & Safety, Laboratory & Instrument management. Malin is a certified Lead auditor within cGMP, ISO 13485, QSR 820, ISO 9001 and ISO 14001.
Megi has a master’s degree (M.S) in European Business law from Lund University. She has completed her doctorate (Ph.D) in Law at Lund University. Megi is the in-house senior legal counsel and supports the company in its listing in 202, acquisitions, mergers and legal compliance programs. Her tasks, among others, include contract management, corporate actions, and compliance with market rules.
Mona is the Human Resource Manager since 2010. Mona has a B.Sc. in Informatics and more than 15 years of experience in the life science industry within HR, Sales & Marketing and administration. She has a hands-on mentality and has been involved in the company’s digitization projects, mergers and development of a flat organization, agile principles and continuous education and knowledge advancement for the employees.
A Dedicated R&D Team Leader and a researcher with background in organic and medicinal chemistry with over 10 years of experience in the pharmaceutical industry. Emphasis in the CDMO business and more recently also within the field of Medical Device, working with development and scale-up of active pharmaceutical ingredients and med. tech. products spanning all the way from early to late-stage clinical phases. Always striving to support Team members and other Teams to perform in creative and productive manners.
Thomas has 30+ years’ experience within global pharmaceutical industry, encompassing project support from early pre-clinical phase trough all phases of late-stage development and registration for market. Thomas main expertise are within Solid -State and Material Science areas, including knowledge-building on the interrelationship between physical properties, stability and functionality of formulations and products. Today, Thomas is responsible for the management of our Inhalation and Solid-State services.